Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and the risk of developing rheumatoid arthritis in antihypertensive drug users

Hilda J. I. de Jong, Rob J. Vandebriel, Siti R. F. Saldi, Liset van Dijk, Henk van Loveren, Jan Willem Cohen Tervaert, Olaf H. Klungel

Research output: Contribution to journalArticleAcademicpeer-review

6 Citations (Scopus)
Original languageEnglish
Pages (from-to)835-843
JournalPharmacoepidemiology and Drug Safety
Volume21
Issue number8
DOIs
Publication statusPublished - Aug 2012

Keywords

  • angiotensin-converting enzyme inhibitor
  • angiotensin II receptor blocker
  • rheumatoid arthritis
  • autoimmune
  • immunomodulation
  • case-control study
  • pharmacoepidemiology

Cite this